Contravisory Investment Management, Inc. Procept Bio Robotics Corp Transaction History
Contravisory Investment Management, Inc.
- $453 Million
- Q3 2024
A detailed history of Contravisory Investment Management, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 5,095 shares of PRCT stock, worth $413,561. This represents 0.09% of its overall portfolio holdings.
Number of Shares
5,095
Previous 5,095
-0.0%
Holding current value
$413,561
Previous $311,000
31.19%
% of portfolio
0.09%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
266Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$393 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$283 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$125 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$101 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$95.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.62B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...